Insider Transactions in Q4 2025 at Ultragenyx Pharmaceutical Inc. (RARE)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2025
|
Theodore Alan Huizenga SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
85
-0.17%
|
$2,890
$34.38 P/Share
|
|
Dec 10
2025
|
Howard Horn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,081
-3.14%
|
$110,916
$36.38 P/Share
|
|
Oct 13
2025
|
Howard Horn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,942
-7.48%
|
$246,202
$31.51 P/Share
|